You are here:
» CD38 is a potential treatment target in lymphoma patients...
About Aarhus University
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review
DOI
- https://doi.org/10.1080/10428194.2021.2023741
Final published version
- Trine Engelbrecht Hybel
- Maja Ølholm Vase ,
- Kristina Lystlund Lauridsen
- Marie Beck Enemark
- Michael Boe Møller, University of Southern Denmark ,
- Court Pedersen, University of Southern Denmark ,
- Gitte Pedersen, Aalborg University ,
- Stephen Hamilton-Dutoit
- Niels Obel, University of Copenhagen ,
- Carsten Schade Larsen
- Francesco d’Amore
- Maja Ludvigsen
| Original language | English |
|---|---|
| Journal | Leukemia and Lymphoma |
| Volume | 63 |
| Issue | 6 |
| Pages (from-to) | 1479-1483 |
| Number of pages | 5 |
| ISSN | 1042-8194 |
| DOIs |
|
| Publication status | Published - May 2022 |
See relations at Aarhus University Citationformats
ID: 278011186